Lv51
870 积分 2025-02-05 加入
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
4天前
已完结
Rational Engineering of Notch1 Signaling to Boost the Proliferation of CD19-BBζ CAR-T
1个月前
已完结
The landscape for in vivo CAR T cell therapies
1个月前
已完结
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
1个月前
已完结
Pre-intervention with intravenous immunoglobulin reverses the immunogenic clearance of PEGylated nanomedicines
1个月前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
1个月前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
1个月前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
1个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
1个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
1个月前
已完结
皖公网安备34019202002308
